Skip to main content
PLOS One logoLink to PLOS One
. 2025 Apr 29;20(4):e0321064. doi: 10.1371/journal.pone.0321064

In silico studies provide new structural insights into trans-dimerization of β1 and β2 subunits of the Na+, K+-ATPase

Gema Ramírez-Salinas 1, Liora Shoshani 2,*, Jorge L Rosas-Trigueros 3, Christian Sosa Huerta 2, Marlet Martínez-Archundia 1,*
Editor: Colin Johnson4
PMCID: PMC12040271  PMID: 40299990

Abstract

The Na+, K+-ATPase is an electrogenic transmembrane pump located in the plasma membrane of all animal cells. It is a dimeric protein composed of α and β subunits and has a third regulatory subunit (γ) belonging to the FXYD family. This pump plays a key role in maintaining low concentration of sodium and high concentration of potassium intracellularly. The α subunit is the catalytic one while the β subunit is important for the occlusion of the K+ ions and plays an essential role in trafficking of the functional αβ complex of Na+, K+-ATPase to the plasma membrane. Interestingly, the β1 and β2 (AMOG) isoforms of the β subunit, function as cell adhesion molecules in epithelial cells and astrocytes, respectively. Early experiments suggested a heterotypic adhesion for the β2. Recently, we reported a homotypic trans-interaction between β2-subunits expressed in CHO cells. In this work we use In Silico methods to analyze the physicochemical properties of the putative homophilic trans-dimer of β2 subunits and provide insights about the trans-dimerization interface stability. Our structural analysis predicts a molecular recognition mechanism of a trans-dimeric β2β2 subunit and permits designing experiments that will shed light upon possible homophilic interactions of β2 subunits in the nervous system.

Introduction

The Na+, K+-ATPase, a ubiquitous plasma-membrane ion pump plays a crucial physiological role in all animal cells. Indeed, the resultant ion and electrochemical gradients are essential for many physiological processes and in the brain, about 50% of the ATP is consumed by the Na+, K+-ATPase [1]. Na+, K+-ATPase is a P-type ATPase, an oligomeric enzyme that consists of three subunits: α, β and γ [2,3]. This work is focused on the β-subunit. The Na+, K+-ATPase β subunit is part of the functional core of the pump and is required for its trafficking to the plasma membrane. Mammals express three β subunit isoforms, β1, β2 and β3. It has a small intracellular, N-terminal domain (30 amino acids), a single transmembrane helix, and a large extracellular, C-terminal domain of about 240 amino acids [4,5]. The different β isoforms have distinct tissue and cell-type specific expression profiles [6,7]. There are three conserved disulfide bonds in the extracellular domain, which are important for forming a stable pump [8], and the extracellular domain has three, eight, and two glycosylation sites in β1, β2, and β3, respectively [9,10]. Functionally, β2 has the strongest effects on the kinetic properties of the pump, reducing the apparent potassium affinity and raising the extracellular sodium affinity compared to β1 and β3 [11]. The different β isoforms and the variation in their post-translational modifications facilitate regulated Na+, K+-ATPase activity, adapted to different tissues and to environmental changes. The β subunit is important for the occlusion of the K+ ions and plays an essential role in trafficking of the functional αβ complex of Na+, K+-ATPase to the plasma membrane [12]. Apart from the role of β subunit in regulating the pump activity, a role in cell-cell adhesion has been also proposed [13]. With this regards, [13] have suggested that the Na+, K+-ATPase acts as a cell adhesion molecule by binding to the Na+, K+-ATPase molecule of a neighboring cell by means of trans-dimerization of their β1 subunits. Following, it was demonstrated that a direct homotypic interaction between β1-subunits of neighboring cells, takes place between polarized epithelial cells [14,15] identified the amino acid region crucial for the species-specificity of this trans-interaction [16] completed the description of the adhesion interface between the extracellular-domains of the dog β1-subunits. Earlier, the group of Schachner identified an adhesion molecule on glia (AMOG) that functions as a neural recognition molecule mediating neuron-glia interactions that promotes migration and neurite outgrowth [17,18]. This adhesion molecule was later identified as the β2-subunit of the Na+, K+-ATPase and was named β2/AMOG [19]. Their works suggested a heterophilic interaction between AMOG and an unknown molecule at the neuron membrane [19,20]. The crystal structure analysis of the Na+, K+-ATPase β1 subunit in the E2 state as published by Shinoda and colleagues, marked a significant milestone by revealing the atomic structure of the extracellular domain of the β1 subunit (PDB: 2ZXE) [21]. Notably, the extracellular C-terminal domain of the protein adopts an Ig-like β-sheet sandwich configuration, consistent with in silico predictions [22]. Intriguingly, although many adhesion and non-adhesion proteins feature domains with an immunoglobulin-like (Ig-like) topology, structural alignments of the β1-subunit extracellular domain against well-studied cell adhesion molecules do not reveal any structural homologs to β subunits. Upon detailed examination, three distinctive features of the β subunit family members emerge: 1. The Ig-like fold with a unique topology, interrupted by a long α-helix secondary structure. 2. An atypical β-sheet disposition in relation to classical Ig folds. 3. The β subunit fold contains extensive loops, resulting in a length twice that of a typical Ig domain. Furthermore, the structural relationship between the β1 subunit and the catalytic α subunit suggests that the C-terminal fold must exhibit greater rigidity compared to the typical flexibility seen in adhesion domains, such as cadherin-domains [23]. Further works including mutational analysis combined with In Silico studies have identified the residues at the dog β1 surface that participate in β1β1 interaction [15,16]. Although It is well accepted that both isoforms β1 and β2 function as adhesion molecules in epithelia and in the nervous system, respectively there is almost no information regarding the adhesion mechanism of β2 /AMOG isoform. Very recently it has been published that β2 acts as an homophilic adhesion molecule when expressed in CHO fibroblasts and MDCK epithelial cells [24]. Cell-cell aggregation, protein-protein interaction assays as well as In Silico studies were carried out to confirm cell-cell adhesion mediated by β2β2 trans-interaction. With these results the authors localized the putative interacting surface in a docked model and suggested that the glycosylated extracellular domain of β2/AMOG, can make an energetically stable trans-interacting homodimer. In the present work we have built homotypic dimers of the human β1 and β2 subunits by employing protein-protein docking analysis, and submitted them to molecular dynamics simulations (MDS) which provide detailed information about their dimeric conformation and specific differences in their interfaces. We also investigated the role of the glycosylation in the interface stabilization of the human β1 and β2 dimeric complexes.

Materials and methods

Molecular modeling of the monomers of Na+, K+-ATPase β subunits in humans

Three dimensional (3D) structures of the β-subunits of Na+, K+-ATPase: ATP1B1 and ATP1B2 were obtained by employing the Swiss Model Program [25]. For the In Silico studies of both proteins we considered only the extracellular domain of the Na+, K+-ATPase β1 and β2 subunit.

The glycosylation and disulphide bridges sites on both ATP1B1 and ATP1B2 were taken from the Uniprot database ATP1B1 (P05026) and ATP1B2 (P14415) [26]. For the first protein (β1), the following glycosylation sites were considered: N158, N193 and N265, and the disulphide bridges: S126–S149, S159–S175 and S213–S276. For the second protein (β2), the following glycosylations were considered: N96, N118, N153, N159, N193, N197 and N238, whereas the following disulphide bridges were considered: S129–S150, S160–S177 and S200–S261. Glycosylations (GlcNAc) and disulphide bridges of each of the proteins were included by means of the CHARMM-GUI Program [27].

Building the dimers of ATP1B1 and ATP1B2 and validation of the 3D models

Once the monomers were correctly built, the molecular docking of both β1β1 and β2β2 subunits was performed by using HDOCK server in order to obtain dimer complexes of each of the proteins. HDOCK predicts the interaction of protein-ligand complexes through hybrid algorithm strategy of template-based and template-free docking [28].

After performing protein-protein docking procedure, dimeric complexes were selected according to the criteria a) most energetically favorable β1β1 (Docking score -193.04 kcal/mol) and β2β2 (Docking score -274.99 kcal/mol), by means of the HDOCK Server [28], b) trans orientation in the dimeric complexes.

Molecular dynamics simulations of dimeric complexes of β1β1 andβ2β2

MD simulations of both dimers were carried out using CHARMM-GUI Server and considering the commands from the Solution Builder implemented in the mentioned Program. Dimers were in a rectangular waterbox size of 10Å edge distance. A NaCl solution (0.15 M) was integrated in the system by using “Distance” as Ion Placing Method [29]. Periodic Boundary Conditions were implemented as Generating grid information for PME FFT automatically. Equilibration of the systems was done using an NVT ensemble and dynamics input was generated as an NPT ensemble (310 K). MD simulations were run for about 200 ns.

Analysis of the interfaces of the dimeric complexes of β1 and β2

Molecular interactions were analyzed in the different protein conformations which include: hydrogen bonds (kJ/MOL), electrostatic energy (kJ/MOL), Van der Waals (kJ/MOL), and Total stabilizing energy (kJ/MOL). All these parameters were calculated through PPCHECK Software [30] which is a specialized web server useful to identify non-covalent interactions at the interface of protein-protein complexes. Moreover, the percentage of residues in the interface, for both chains (chain A and chain B) was calculated using the Program PDBePISA from the Protein Data Bank in Europe [31].

For this analysis we compared three different conformations at 0 ns, 20 ns, 60 ns, 100 ns, 120 ns and 160 ns. Protein-protein interactions in the interfaces were calculated through PDBsum (http://www.ebi.ac.uk/thornton-srv/databases/pdbsum/) in which interface areas are computed using Program called NACCESS http://wolf.bms.umist.ac.uk/naccess, which is implemented in the Software.

Prediction of binding free energy through Molecular Mechanics Poisson–Boltzmann Surface Area (MM-PBSA) method

Binding free energies of the dimeric complexes of ATP1B1 and ATP1B2 were calculated by means of the pipeline tool named Calculation of Free Energy (CaFE) which is a useful tool to predict binding affinity of some complexes by using end-point free energy methods [32] with the aim to conduct MM-PBSA calculation [33]. In the MM-PBSA analysis, three main energetic components are calculated. Firstly, the gas-phase energy difference between the complex and the receptor separated. Afterwards, the difference of solvent-accessible surface area (SASA) is measured and the non-polar solvation free energy is calculated. Finally the binding free energy is added throughout an ensemble conformations. By means of this analysis we were able to get an insight about non-bonded interactions such as Van der Waals, electrostatic, among other parameters.

Principal component analysis (PCA)

PCA has become a popular method to reduce the dimensionality of a complex system and has been previously applied to G protein-coupled receptors (GPCRs) [34]. This method diagonalizes the two-point covariance matrix, thus removing the instantaneous linear correlations among the atomic positions. It has been shown that a large part of the system’s fluctuations can be described in terms of only a few of the eigenvectors obtained, usually those corresponding to the largest eigenvalues. The principal components are the product of these eigenvectors with the mass weighted coordinates of the molecule and can be used as reaction coordinates and to obtain free energy surfaces of the system, among other analysis that can be performed of this representation of the conformational behavior. We used the dihedral angle principal component analysis (dPCA) version, as modifications in dihedral angles lead often to more dramatic conformational changes than movements in atomic cartesian coordinates [35]. The calculations were performed using the Carma program [36].

Free energy landscapes

The calculated dPCA were used to represent the free energy surface of the system, restricting the surface to two dimensions (thus using the first two principal components V1 and V2):

ΔG(V1,V2)=kBT[lnρ(V1,V2) lnρmax] (1)

where ρ is an estimate of the probability density function obtained from a histogram of the data. ρmax denotes the maximum of the density, therefore ΔG = 0 for the region with the highest density [35].

PCA-based cluster analysis

The calculated dPCA values for each trajectory frame are used to populate a grid to describe the distribution of these values: the higher the value at a grid point, the larger the number of frames with dPCA values closest to this grid point. Isolated maxima in this distribution map correspond to heavily populated clusters. Cluster number 1 is the cluster with the highest density, which would correspond with the region where ΔG = 0 in the free energy landscape described above.

Contribution of movements in each of the residues along the trajectories

In the dPCA, each principal component Vk is given by

Vk=v(k)q=v1(k)cosγ1+v2(k)sinγ1++v2N1(k)cosγN+v2N(k)sinγN (2)

Where v(k) is the kth eigenvector and {γn},n=1,...,N, is the sequence of dihedral angles  ( ϕ , ψ )  of the peptide backbone.

A measure of the influence of angle γn on the principal component Vk may be defined as

Δn(k)=(v2n1(k))2+(v2n(k))2 (3)

The length of each eigenvector is 1, and thus ΣnΔn(k)=1. Δn ( k )  can hence be considered as the percentage of the effect of the angle γn on the principal component Vk [35]. These contributions per dihedral angle were calculated for the first principal component (Δn ( 1 ) ) for both ATP1B1 and ATP1B2.

Results

Molecular modeling of human ATP1B1 and ATP1B2

The β-subunit of the sodium pump is a membrane protein with a single transmembrane helix and most of the mass folded as a Ig-like β-sandwich at the extracellular space [16,22]. Since the structure of the extracellular domain is stable and active [14,16,3739], we decided to analyze its adhesive properties without the cytoplasmic and transmembrane domains as they do not participate in the β-β trans-interaction. The identity between human β1 subunit (P05026) and wild boar β1 subunit (3WGU) is 92.41%. As we were interested in studying the intermolecular interactions, we had to consider that the 7.6% difference in sequence could result in a different behavior of protein-protein interactions. Therefore, it was important to work with a structural model. The three dimensional (3D) model of the extracellular domain of human Na+, K+-ATPase β1 subunit (ATP1B1) was built by considering the crystal structure of the Na+, K+-ATPase 3WGU from wild boar (Sus scrofa) and the Fasta Sequence of Uniprot (P05026). When we compare the 3D structure of those two proteins, (the model for human β1 and wild boar β1) we find a homology of 95.5%. In Fig 1A the 3D model of the extracellular domain of β1 subunit is depicted, considering residues 63 to 303. The three N-glycosylation sites: Asn158, Asn193 and Asn265 at the surface of the extracellular domain, the three disulfide bridges and the characteristic Ig-like β-sandwich structure are shown. Validation of the 3D model was carried out by employing Ramachandran plots, where it could be seen that 99% of the residues are included in permitted zones of the protein (Fig 1B). Since no crystal structure was available for the β2 subunit of any species, the 3D model of the extracellular domain of human ATP1B2 was built by considering the crystal structure of the homologous (Identity: 40% and Convergence: 98%) pig gastric H+,K+-ATPase- 5YLU and the Fasta Sequence of Uniprot (P14415). In Fig 1C, the following structural features of the extracellular domain (residues 70 to 289) of β2 subunit are shown: seven N-glycosylation sites, three disulphide bridges and a characteristic Ig-like β-sandwich structure. Validation of the 3D models was carried out by employing Ramachandran plots, where it could be seen that 100% of the residues are included in permitted zones of the protein (Fig 1D).

Fig 1. Three-dimensional structure of monomeric β1 subunit (ATP1B1) and β2 subunit (ATP1B2).

Fig 1

A) 3D structure of the β1 subunit monomer including its glycosylations. B) Ramachandran plot of the β1 subunit monomer where it can be seen that only 1% of the residues of the proteins are included in the disallowed regions. C) 3D structure of the β2 subunit monomer including its glycosylations. D) Ramachandran plot of the β2 subunit monomer where it can be seen that none of the residues of the proteins are included in the disallowed regions. The extracellular domains of the β1 and β2 subunits depicted in A and C are with the N-terminal (residues 63 and 70) colored in yellow and the C-terminal (residues 303 and 289) in green. The distinctive alpha-helix of the β-subunits is localized in the bottom. For relative orientation to the alpha subunits, see S7 Fig.

Building of the dimers β1β1 and β2β2

The molecular docking of the extracellular domains of both β1β1 and β2β2 subunits was performed by using HDOCK Server. In that protein-protein docking process, the most energetically favorable conformers were chosen, for β1β1 that of -193.04 kcal/mol and for β2β2 that of -274.99 kcal/mol) by means of the HDOCK Server. Among the favorable conformers, as a second structural criteria, we considered only the trans-dimers for further analyses. In the present work we considered pertinent to include the glycosylations in modeling, docking and MD simulations since it was demonstrated that N-glycosylation of both extracellular domains of β1 and β2 subunits are crucial for cell-cell adhesion [16,24]. In Fig 2 the selected trans-dimers were depicted.

Fig 2. Dimeric 3D structure of β1 subunit and β2 subunit in trans orientation.

Fig 2

A) Dimeric structure of β1β1. B) Dimeric structure of β2β2. For both cases Chain A is colored in purple and Chain B is colored in blue. Glycosylations are marked in balls and sticks.

Molecular Dynamics Simulations of the dimers β1β1 and β2β2

Molecular dynamics simulations (MDS) were carried out on both dimeric complexes depicted in Fig 2, and trajectories were run for 200 ns. Furthermore, structural analysis was done with the Carma Program as described in “Methods”. In agreement with previous results with dog ATP1B1 [16], the RMSD values for the soluble ectodomain of human β1β1 are within the range of 6-8Åeven though, the present model includes the three glycosylated residues. Fig 3 shows that there are no apparent structural differences between β1β1 and β2β2 dimers. Nevertheless, the surface residues that constitute the adhesion interface in the two dimers were different. Therefore, we decided to analyze both interfaces to get a better understanding about their formation and stability.

Fig 3. Structural Analysis of ATP1B1 and ATP1B2 dimers: A) Root mean square deviation analysis (RMSD) of the dimers β1 and β2.

Fig 3

A) Root mean square deviation analysis (RMSD) of the dimers β1 and β2 . Root mean square fluctuation (RMSF) analysis of the alpha carbons of the dimers β1β1 (B) and β2β2 (C).

Analysis of interactions in the β − β interfaces

Protein-protein interactions are important for normal biological processes since they play a key role in the regulation of cellular functions that affect gene expression and function [40]. In this work we present an analysis of the residues at the interface of protein-protein interaction, thus providing information about the stability and specificity of the complex. In the analyses of the interfaces, the properties to be considered include: hydrogen bonding, buried surface area and hydrophobicity among others [41]. PPCHEK server was employed to get an insight on the non-bonded interactions that are present in the dimeric complexes (β − β) obtained from the MD simulations. These interactions in KJ/mol include: Hydrogen bonds, electrostatic energy, Van der Waals energy, and total stabilizing energy. PPCheck, can also predict reliably the correct docking pose by checking if the normalized energy per residue falls within a standard energy range of -2kJ/mol to -6kJ/mol which was obtained by studying a large number of well characterized protein-protein complexes [30]. Additionally, the percentage of residues in the interface of each of the dimers, at the different conformations, was investigated using the PDB-PISA server. Analysis of the following conformations: 0, 20, 60, 100, 120, 160 and 170 ns, was carried out employing the mentioned servers and are summarized in Tables S1 Table and S2 Table. A general observation is that the number of interface residues in the different conformations of β1 dimers vary from that of β2 dimers. This difference tends to be remarkable in the earlier protein conformations of the molecular dynamics simulations (S1 Table). The majority of the conformations (0, 20, 60, 100, 120 ns) of β1 dimers show lower stabilizing energy in comparison to the conformations for β2 dimers. The normalized energy per residue is around -2 kJ/mol in various conformers of β1β1 while in β2β2 none of the conformers reached that value. Thus, suggesting that in general, β1 dimer is more stable in comparison to β2 dimer (S2 Table). Even though selected snapshots were useful to depict structural differences in the distinct protein conformations, they seem not to reflect dynamics characteristics of both interfaces. Therefore, we used other tools in order to analyze and compare the dimeric interfaces.

Searching for hot spots within dimeric interfaces

Protein-protein interactions in the interfaces were calculated through PDBsum software. Fig 4 depicts protein-protein interactions of the conformers of β1β1 and β2β2 taken at different times: 0,100,120 and 160 ns. The residues in the interface are depicted and some residues show to be constant in the interface of most of the conformers, for β1β1: Lys173, Gly225, Asn226, Glu228, Thr264, Leu266 and for β2β2: Arg130, Thr155, Ile163, Asn220 which are therefore considered the hot spots residues. The analysis of hot spot residues in each dimer suggests significant differences in the interfaces involved in homophilic protein-protein interactions between the β1 and β2 subunits of Na+, K+-ATPase across neighboring cells.

Fig 4. Interfaces at ATP1B1 and ATP1B2 dimers.

Fig 4

Graphical representation of the protein interfaces at β1 and β2 dimers in different snapshots obtained from the MD simulations using PDBSUM server. (*) Residues that appear in all conformations are marked as hot spots.

The multiple sequence alignment presented in Fig 5 indicates that, despite high homology between the two subunits, the surface regions engaged in trans-dimerization differ. Notably, the hot spot residues of the β1 dimer are clustered in close proximity, while those of the β2 dimer are more widely dispersed across the surface. In this alignment, we compared the sequences of the dog ATP1B1 interface, as described in references 15 and 16, with those of human ATP1B1 and ATP1B2 examined in this study. Our findings reveal that: i) β2 lacks segment 1 present in both dog and human β1 (indicated by the orange box); ii) human β1 shares hot spot residues with dog β1 (highlighted in the green box); iii) residues Glu228, Lys173, Thr264, and Leu266 are conserved in both ATP1B1; and iv) residues Gly225 and Asn226 are identical across the three sequences. In relation to the hot spot residues of ATP1B2, we found that i) Arg130, Thr155, and Asn220 exhibit a lack of conservation; ii) although Ile163 is identical across the three sequences, it is exclusive to the β2β2 interface. Additionally, while human ATP1B2 shares Gly225 and Asn226 within segment 2, these residues do not seem to influence the β2β2 interface. Collectively, these structural distinctions provide insights into the observed differences between the dimer interfaces of β1 and β2.

Fig 5. Multiple sequence alignment of ATP1B1 and ATP1B2.

Fig 5

A multiple alignment is shown (ATP1B1 Human (P05026), ATP1B1 Dog (P06583), and ATP1B2 Human (P14415). Yellow Arrows: Hot Spots residues of human ATP1B1. Red arrows: Hot spots residues of human ATP1B2. Orange box: Dog Sequence 1 from ref. 15 and Green box: dog Sequence 2 from ref. 16.

Monitoring interactions that involve the hot spot residues

Fersht and coworkers provided valuable information regarding the role of hydrogen bonds in protein stabilization [42]. Afterwards, several experimental studies were carried out on proteins of different nature, for example: BPTI [43], RNase Sa [44], Staphylococcal nuclease [45], human lysozyme [46]. In this work, one of the aims was to get insights about hydrogen bonds that are located in β1β1 and β2β2 dimers. For the case of β1, from the three hot spot residues we could identify the formation of hydrogen bonds between the residues: Asn226A and Thr264B (Fig 6A). On the other hand, the hot spot residues in β2β2 identified as forming hydrogen bonds are Asn220A and Thr155B. These Hydrogen bonds were monitored along the trajectories of both β1β1 and β2β2 dimers. Fig 6A describes a constant hydrogen bond between residues Asn226A and Thr264B in β1 dimer, since the first 20 ns of simulation. Fig 6B shows the formation of the hydrogen bond between Asn220A and Thr155B in β2 dimer just after 100 ns of simulation. These results indicate a clear difference in the dynamics of the dimers formation and strongly suggest that these hydrogen bonds play a key role in the stabilization of the dimer.

Fig 6. Constant hydrogen-bonds in β1 and β2 dimers.

Fig 6

Distance between atoms (Asn226A:HD21-Thr264B:OG1) for β1 and (Asn220A:ND2-Thr155B:O) for β2 were calculated along the trajectories using Carma Software.

Participation of N-glycosylated residues in the dimeric interface

N-Glycosylation involves adding oligosaccharides to the nitrogen atom of Asn in the Asn-X-Ser/Thr sequence of glycoproteins. This type of glycosylation is prevalent in many human proteins and is important for protein folding and stability of the protein [47], and targeting specific cellular locations [48,49]. All eukaryotic N-glycans share a common core of two N-acetylglucosamine (GlcNAc) and three mannose residues, which are further modified into diverse structures. Based on protein and cell type, N-glycans are classified as high-mannose, complex, or hybrid oligosaccharides. They regulate protein stability, solubility, trafficking, and cell signaling [4750], Notably, human β1 and β2 isoforms differ in their N-glycosylation sites, with β1 having three and β2 seven. N-glycosylation is crucial for β − β interactions, as its inhibition disrupts cell adhesion [24,49,51]. In our models for human β1 and β2 subunits, we introduced only the GlcNAc into the corresponding asparagines. Here, we identified the N-glycosylation sites (GlcNAc) located in the interfaces of β1β1 and β2β2 and their interactions with the surrounding residues at different conformers obtained from the MD simulations (0, 20, 60, 100, 120, 160, 170 ns). Tables Table 1 and Table 2 summarize the interacting glycans of N-glycosylated residues in each dimer and are centered in the table and labeled in red. For the case of the glycosylated Asparagines in β1 dimer (Table 1), all the identified interactions are intramolecular, with residues of the same chain and are mainly through Van der Waals interactions. The most frequent intramolecular interactions with the glycosylation of Asn265 is through Van der Waals interactions, although few intramolecular hydrogen bonds were identified within the B chain (Thr267B y Thr270B). Noteworthy is the interaction with Thr264 considered a hot spot residue in β1β1 interface.

Table 1. Glycan-protein interactions of ATP1B1 (β1 dimer).

N-linked glycosylation in ATP1B1: Asn158, Asn193 and Asn265
Residue Conformations (ns) Residue Conformations (ns)
0 20 60 100 120 160 170 0 20 60 100 120 160 170
GlcNAcAsn158A GlcNAcAsn158B
Glu154A Glu154B
Trp155A Trp155B
Gly157A Gly157B
Asn158A Asn158B
Phe230A
GlcNAcAsn193A GlcNAcAsn193B
Asn193A Asn193B
GlcNAcAsn265A GlcNAcAsn265B
Phe263A Val224B
Thr264A Phe263B
Asn265A Thr264B
Ile272A Asn265B
Thr267B
Thr270B
Ile272B

Different conformations of the protein are shown as rectangles (0, 20, 60, 100, 120, 160 and 170 ns). Interactions of the glycans are marked with different colors as follows: Van der Waals (green), Hydrogen bonds (blue) and Carbon-Hydrogen (purple).

Table 2. Glycan-protein interactions of ATP1B2 (β2 dimer).

>N-linked glycosylation in ATP1B2: Asn118, Asn153, Asn159 and Asn197
Residue Conformations (ns) Residue Conformations (ns)
0 20 60 100 120 160 170 0 20 60 100 120 160 170
GlcNAcAsn118A GlcNAcAsn118B
Asn118A Asn118B
GlcNAcAsn153A GlcNAcAsn153B
Asp119A Asp119B
Gln122A Asn153B
Ala123A Thr155A
Gln151A Gln156A
Thr155A Phe217A
GlcNAcAsn159A GlcNAcAsn159B
Val128B Asn118A
Arg130B Arg154A
Asn159A Asn159B
Asp165A
Met226B
GlcNAcAsn153A
GlcNAcAsn197A GlcNAcAsn197B
Asn193B

Different conformations of the protein are shown as rectangles (0, 20, 60, 100, 120, 160 and 170 ns). Interactions of the glycosylation are marked with different colors as follows: Van der Waals (green), Hydrogen bonds (blue) and Carbon-Hydrogen (purple).

Table 2 shows the most frequent interactions with the glycans in the interface of the dimer β2β2. Two glycosylated residues, Asn118 and Asn197, show few interactions, mainly intramolecular ones. The other two are more interactive. Asn153A interacts with residues of the same chain mainly through Van der Waals interactions. Nevertheless, Asn153B interacts with residues of the contrary chain through Van der Waals and hydrogen bonds; a similar behavior is observed with Asn159A and Asn159B. Of worthy interest, residues Arg130B and Thr155A which we identified as hot spots within β2β2 interface, interact with the glycans of Asn159A and Asn153B, respectively.

Prediction of Binding Free energy through MM-PBSA method

Here we present an easy-to-use pipeline tool named Calculation of Free Energy (CaFE) to conduct Molecular Mechanics Poisson-Boltzmann Surface Area (MM-PBSA) and LIE calculations. Powered by the VMD and NAMD programs, CaFE is able to handle numerous static coordinate and molecular dynamics trajectory file formats generated by different molecular simulations. The MM-PBSA approach has been widely applied as an efficient and reliable free energy simulation method to model molecular recognition, such as for protein-ligand binding interactions [33]. Moreover, MM-PBSA and MM-GBSA methods are useful methods in both accuracy and computational effort between empirical scoring and strict alchemical perturbation methods [52]. Binding free energy of the dimer complexes β1 and β2 was calculated by CaFE to conduct MM-PBSA [32] and the obtained values are presented in Table 3. It can be seen that the major contribution to the free energy of the complex is due to polar interactions. Dimeric complex of β2 shows higher binding free energy in comparison to the dimeric complex of β1 (–19707.5 vs –22671.13 kcal/mol) .

Table 3. MM-PBSA calculation of ATP1B1 (β1) and ATP1B2 (β2) dimeric complexes.

Protein Electro-static (kcal/mol) Van der Waals (kcal/mol) Poisson-Boltzmann (kcal/mol) Surface Area (kcal/mol) Gas (kcal/mol) Solvate (kcal/mol) Polar interactions (kcal/mol) Non Polar interactions (kcal/mol) Total (kcal/mol)
ATP1B1 –11375.42 –1664.37 –9782.35 151.007 –13039.79 –9631.34 –21157.77 –1513.361 –22671.1333
ATP1B2 –9546.50 –1514.63 –8784.48 138.04 –11061.14 –8646.44 –18330.98 –1376.600 –19707.5810

Principal component analysis (PCA)

In Silico approaches are useful to describe protein dynamics, in which fluctuations range from bond-distance variations. Molecular dynamics simulations along with mathematical applications are very helpful to investigate these fluctuations that occur in the proteins. Principal component analysis (PCA) is a useful mathematical technique to reduce a multidimensional complex set of variables to a lower dimension. This technique has been used to investigate the stages of protein folding in proteins of diverse nature [53]. In general, the great majority of proteins show particular behavior in which their two/three principal components describe the main motions of the proteins (about 70-80%). As we can infer from our results, the cumulative contribution to the variance in the conformational space is the largest for the first two principal components, 50% and 30% for β1 and β2 respectively (S1 Fig). Dihedral angle principal component analysis (dPCA) has shown advantages for the treatment of proteins and was therefore used for this study. We studied the fluctuations of these principal components (PC1 and PC2). Projection of the trajectories onto PC1 and PC2, together with the cluster analysis (where the region with the highest density is highlighted as cluster 1) is depicted in S2 Fig. The free energy landscapes obtained from the dPCA analysis (Fig 7) show the region with the highest density as the deepest basin (ΔG = 0). We observed that β1 homodimer presents low values for PC1 (around 0) and high values for PC2 (around 5) in its region with the highest density, which is rather localized. On the other hand, the region with the highest density for β2 homodimer spans a large region where values for PC1 range from -6 to -2 and values for PC2 range from -4 to 1. Having a high density region with the largest principal component close to zero as is the case for β1 dimer suggests the formation of a stable interface that has a short-ranged oscillation. On the other hand, large absolute values in the largest principal component of the region with the highest density, as observed for β2 dimer, suggest that under these conditions a stable dimer is not yet reached. The motions associated with PC1 and PC2 for β1 dimer both show symmetric, rotatory behaviors, whereas, PC1 for β2 dimer shows a longitudinal motion and PC2 seems to involve substantially the most mobile loops; this participation of the loops in PC2 suggests that a concerted motion involving the interface has not been reached for this complex (Fig 8, S3 Fig to S7 Fig and Supplementary Videos).

Fig 7. Free energy landscapes considering the first two principal components of β1β1 and β2β2 dimers.

Fig 7

Fig 8. Motion associated with PC1 and PC2.

Fig 8

Chain A goes from red in the N-terminus to white in the C-terminus while chain B goes from white in the N-terminus to blue in the C-terminus. Green tubes show the motion associated with the principal components.

Analysis of the movement contributions per dihedral angle

In the dPCA, each dihedral angle γ is transformed into a space with two coordinates (cos ⁡  γ, sin ⁡  γ). Each principal component has a weight calculated for each of those coordinates and a measure of the influence of angle γ on principal component k (Δγ ( k ) ) is defined as the sum of the squares of the corresponding weights, as detailed in section 4.8. The contribution to the first principal component from every angle (Δ ( 1 ) ) was calculated (S8 Fig). For β1, elevated contributions are observed in the vicinity of interface residues Val129, Pro130, Glu132 and Pro133 in Chain A, and in the vicinity of interface residues Glu165, Thr166, Asp218 and Asp220 in Chain B. Thus, all interface residues are close to regions with a large contribution and are therefore participating in the main motion of the complex. These observations suggest a stable interface for this complex. On the other hand, the motion in β2 is quite asymmetrical, while there are major peaks for interface residues Asn193 and Ala265 in both Chain A and Chain B, interface residues Met216, Ala219, Asn220, Gly221, Asn222, Ile223, Asp224 and Lys234 are in a region with a rather small contribution in Chain A and regions with small to negligible contributions in Chain B. Interface residue Gly158 is in a region with almost zero contribution in both Chain A and Chain B. The contribution of residue Asn197A in β2 to the motion is high, whereas Asn197B does not move significantly, probably due to other interactions that restrain this movement. These findings suggest that the interface is not part of the main motion of this complex and is thus not likely to have reached a stable state.

Discussion

Our in silico investigations yield significant insights into the structural dynamics underlying the trans-dimerization process of the extracellular domains of human Na+, K+-ATPase β-subunits, namely ATP1B1 (β1) and ATP1B2 (β2). Previous works have individually studied the structural features of Dog β1 [15,16,37] and human β2 [24], revealing notable molecular and biological distinctions in their adhesive properties. In the current study, we expand upon the analysis of β1 and β2, employing docking and molecular dynamics (MD) simulations and leveraging in silico methodologies to investigate various structural aspects. Our aim is to elucidate the biological disparities observed between β1 and β2/AMOG subunits as adhesion molecules.

Analysis of the interacting interfaces of β1β1 and β2β2 dimers along the MD trajectories

Initially, we examined the interacting interfaces of both β1β1 and β2β2 dimers, revealing a consistent reduction in the number of residues within the interface of β2 dimer throughout the simulation compared to β1 dimer (see Fig. 4). This reduction in residue count corresponds to a lower interface area in β2 dimer, which correlates with reduced complex stability attributable to weaker interactions within this region (Table 5). Furthermore, we identified hot spot residues pivotal for interface stabilization. Notably, the number of hot spot residues within the β2β2 interface was found to be lower than that within the β1β1 interface. The interface of the dimer of human β1β1 that represents the starting point for the molecular dynamic simulation (0 ns in Fig 4) is very similar to that of the dog β1β1 proposed by the in silico and in vitro analyses of [16]. Nevertheless, during the MD simulation the interactions at the interface become less ample and at least 5 residues are identified as hot spots localized in a domain that range between Gly225, and Leu266. On the other hand, the hot spots residues of β2 dimer are more dispersed and indicate a large interface surface. The alignment of human and dog ATP1B1 and human ATP1B2 in Fig 5 shows that indeed the apparent hot spot residues are localized in very distant domains on β2 dimer that do not overlap with those of β1β1 interface. This observation correlates with the MM-PBSA calculations (Table 5) , that shows lower binding free energy for β2 dimer in comparison to β1β1 (-19707.5 vs -22671.13kcal/mol, respectively). Meticulous analyses of the first two principal components from the dPCA performed revealed significant differences in the dynamics of the β1 and β2 dimers. First, the most populated energy region for β1 is rather localized whereas for β2 the most populated energy region spans a large area. Besides, β1 shows a symmetric, concerted rotation involving the interface residues in both monomers, whereas β2 shows a tendency to increase the distance between the monomers in its main motion (PC1), while the second main motion does not involve significantly the interface residues. Additionally, for β1, an important contribution is observed for the dihedrals surrounding Asn158 and Asn193. The former is close to interface residues Glu165 and Thr166 and its pronounced motion could influence this region of the interface. Interface residues Asp218 and Asp220 show important contributions, which suggests their involvement in the concerted motion of the interface. In contrast, most glycosylated asparagines and interface residues show minute contributions for β2 dimer. All these observations are consistent with the existence of a stable interface in β1 dimer and the lack thereof in β2 dimer. Lee et al study, the impacts of N-glycans on the folded glycoproteins in terms of protein structure and dynamics in their glycosylated and deglycosylated forms using an integrated computational approach of the Protein Data Bank (PDB) structure analysis and atomistic molecular dynamics (MD) simulations [54]. This study reveals that N-glycosylation does not induce significant global/local changes in protein structure, but decreases protein dynamics, likely leading to an increase in protein stability. Interestingly, for β2 dimer Asn159A, Asn153B and Asn159B form favorable interactions with residues in the opposite chain (Table 4), which suggests that these glycosylations could play an instrumental role in keeping the dimer despite the motions that tend to separate the monomers.

Biological divergence observed between β1 and β2/AMOGsubunits

Through structural analysis, stability assessments, movement analyses, and free energy calculations, this study reveals that β2, a conventional component of astrocytic Na+-pumps, does not engage in β2β2 trans-dimerization among astrocytes [17], as also demonstrated by protein-protein interaction assays such as pull-down experiments [24]. In contrast, β2 exhibits a propensity for trans-dimerization when expressed in CHO, MDCK, or U87-MG glioma cells [24,55]. These findings suggest the involvement of modulatory elements that promote stable β2β2 interactions in transfected cell lines but inhibit them in astrocytes, potentially masking the trans interaction capacity of β2 in the latter context. Notably, the Na+, K+-ATPase complex in astrocytes, comprising α2 and β2 subunits, has been identified as part of a functional assembly on the astrocytic plasma membrane [56]. This complex regulates lactate transport via coordinated interactions among GluR2, PrP, α2 , β2, basigin, and MCT1. Within this assembly, β2’s N-glycans (oligomannose) interact with the lectin domain of basigin [57]. As specific N-glycosylation sites of β2 are suggested to be at the dimer interface, basigin-β2 interaction would probably impair β2β2 trans-interactions. A relevant participant of cis-interactions with α2 β2 would be the regulatory FXYD protein. Nonetheless, any FXYD protein was detected in that study. As reported recently [7] astrocytes express the FXYD1 (phospholemman) member of that family. Interestingly, FXYD1 stabilizes and protects from thermal inactivation the Na,K-ATPase in a mammalian cell membrane [58]. Thus, it is plausible that the interaction of FXYD1 with β2 is an additional structural constraint that limits the β2β2 trans interactions between astrocytes. While we exclude from this analysis any potential interactions between the extracellular domains of β2, the α2 -subunit, and FXYD1, the possibility of cis interactions involving surface residues within proteins at the same membrane remains to be explored. Future studies should address these gaps to provide a more comprehensive understanding of the structural and functional dynamics of β2 in astrocytes. Of worthy interest is that glycan-protein interactions can be considered as multivalent interactions which are often required to achieve biologically relevant binding even though they are known to have low affinity [59]. On the other hand, these interactions have been related to some other functions which include: dynamic forms of adhesion mechanisms, for example, rolling (cells), stick and roll (bacteria) or surfacing (viruses) [59]. Glycosylations play a pivotal role in cell adhesion and recognition, and can also influence protein-protein interactions. Interestingly, the main difference between the β1 and the β2 isoforms is in their number and sites of N-glycosylation. While human β1(ATP1B1) carries three conserved N-Glycosylation sites, β2 (ATP1B2) conserves these three sites but has 4 additional ones. In the case of cell adhesion mediated by trans-interactions of β1β1 and β2β2, the N-glycosylation of both β-subunits had been reported to play an important role [15,24,49,51]. Here, in a detailed analysis of the interactions of the core-glycosylated residues, we observed that this type of interactions in β1 dimer occur within residues located at the same chain; whereas β2 dimer shows interactions that occur both intra- and inter-molecular, between contrary chains. Understanding the cellular physiology of β2/AMOG is gaining renewed interest due to the increasing evidence implicating Na+, K+-ATPase in neurological pathologies and disorders. Aberrant expressions of different Na+, K+-ATPase subunits and their activity have been linked to the development and progression of various cancers, as well as cancer cell proliferation, migration, and apoptosis [59]. However, the exact mechanism by which Na+, K+-ATPase influences cellular migration and invasion in cancer remains unclear. In the brain, several mutations and aberrant expressions of Na+, K+-ATPase α and β isoforms have been associated with both neurological phenotypes [60] and brain cancer [61]. Remarkably, the majority of Glioblastoma multiforme (GBM) tumors exhibit a dramatic loss of β2/AMOG expression. Sun et al. [61] proposed that this loss may be a key mechanism contributing to the increased invasiveness of GBM cells. They found that overexpression of β2/AMOG reduced the invasion of GBM cells and brain tumor-initiating cells (BTICs) without affecting their migration or proliferation. Conversely, knockdown of β2/AMOG expression in normal human astrocytes increased their invasiveness. Collectively, these findings implicate β2/AMOG in glioma invasion, suggesting that downregulation of β2/AMOG expression is a crucial step in the differentiation of BTICs. Therefore, β2/AMOG is considered a tumor-suppressing protein and is of great interest for understanding its function in the central nervous system. Although our findings suggest that β2 subunit can form homotypic trans-dimers, it does not exclude the proposal of the Schachner group of forming heterotypic interactions that regulate neurite outgrowth and cell migration during development [1719]. Therefore, β2 subunit on astrocyte plasma membrane is probably able to form a stable interface with a yet unknown neural receptor. Various published works appoint the participation of AMOG/β2 subunit in signaling pathways [54,62]. In none of those works, the ligand that activates that signaling pathway was identified. Interestingly, Litan et al. report the participation of β2 subunit in signaling pathways that involve Merlin and EGFR in neuronal granular cells [63]. Their model suggests β2β2 interaction as a switch to activate that pathway. Nevertheless, they do not discuss that point further. Our future work is directed to identify that heterotypic partner of β2 on neurons and study their interaction.

Conclusions

In this study, we identify key structural features underlying the differences on homotypic adhesive functions between β1β1 and β2β2 complexes. First, the interface composition is influenced by sequence and structural variations between the two isoforms. Second, surface glycosylation differs significantly, with β2 exhibiting more N-glycans. While these glycans do not mediate protein-protein interactions in β1, they appear essential for facilitating such interactions in β2. However, the trans-dimer formed by β2 subunits is not a stable complex, suggesting that a stable β2β2 interface may require additional cellular components or co-factors not accounted for in our current model.

Supporting information

S1 Table. Interactions in the interface calculated in the different conformations of ATP1B1 and ATP1B2.

(DOCX)

pone.0321064.s001.docx (138.2KB, docx)
S2 Table. Interactions in the interface calculated in the different conformations of ATP1B1 and ATP1B2 dimers.

The interaction is expressed as pseudo energy, whose ranges have been standardized using known sets of protein-protein complexes.

(DOCX)

pone.0321064.s002.docx (139.6KB, docx)
S1 Fig. Cumulative contribution of the principal components to the variance in the structural space.

The first principal components for both dimers explain under 40% of the energy observed in the simulation. Reaching 80% requires over 100 principal components, which suggests the simulation time might have to be extended to allow fewer motions to dominate the dynamics. The projections of the trajectories onto PC1 and PC2 are very different, which was expected as the sequences show only partial similarity. Regarding the cluster analysis, some clusters of similar size to the main cluster are observed, which correlates with the poor dominance shown by the main principal components and hints at the possibility of a main energetic basin still waiting to be populated. The motions associated with the two main principal components for ATP1B1 show symmetric, rotatory behaviors that are expected in a stable dimer. In contrast, for ATP1B2, PC1 shows an asymmetric, longitudinal motion that seems to drive the monomers away from each other while PC2 seems to involve mostly inconsequential motions in the most mobile loops. This behavior can be related to Table I, where ATP1B2 shows unfavorable interactions for several of the conformations considered.

(TIF)

pone.0321064.s003.tif (240.2KB, tif)
S2 Fig. dPCA Cluster analysis considering the first two principal components of β1β1 and β2β2 dimers.

For ATP1B1 we have the main cluster around low values of PC1, whereas the main cluster for ATP1B2 is in a region with large values for both PC1 and PC2, and it also spans a larger region. These observations support the conclusion that ATP1B1 shows a stable interface and the lack thereof for ATP1B2.

(TIF)

pone.0321064.s004.tif (327KB, tif)
S3 Fig. Motion associated with ATP1B1 dimer, PC1, stereo image.

Chain A goes from red in the N-terminus to white in the C-terminus while chain B goes from white in the N-terminus to blue in the C-terminus. Green tubes show the motion associated with the principal components. The motion for PC1 is concerted, symmetric and rotatory, suggesting that a stable interface is reached in the simulation for this dimer.

(TIF)

pone.0321064.s005.tiff (633.9KB, tiff)
S4 Fig. Motion associated with ATP1B1 dimer, PC2, stereo image.

Chain A goes from red in the N-terminus to white in the C-terminus while chain B goes from white in the N-terminus to blue in the C-terminus. Green tubes show the motion associated with the principal components. The motion for PC2 shows less amplitude than the motion for PC1, but is also concerted, symmetric and rotatory, suggesting that a stable interface is reached in the simulation for this dimer.

(TIF)

pone.0321064.s006.tiff (591.3KB, tiff)
S5 Fig. Motion associated with ATP1B2 dimer, PC1, stereo image.

Chain A goes from red in the N-terminus to white in the C-terminus while chain B goes from white in the N-terminus to blue in the C-terminus. Green tubes show the motion associated with the principal components. The motion for PC1 is longitudinal instead of rotatory and shows a tendency to increase the distance between the monomers, which suggests that a stable dimer is not reached in the simulation.

(TIF)

pone.0321064.s007.tiff (1,002.9KB, tiff)
S6 Fig. Motion associated with ATP1B2 dimer, PC2, stereo image.

Chain A goes from red in the N-terminus to white in the C-terminus while chain B goes from white in the N-terminus to blue in the C-terminus. Green tubes show the motion associated with the principal components. The motion for PC2 does not involve significantly the interface residues, which is consistent with the lack of a stable interface for this dimer.

(TIF)

pone.0321064.s008.tiff (809.3KB, tiff)
S7 Fig. Motion associated with PC1 and PC2 of β1 and β2 dimers, with structural references.

Coloring of the dimers and the associated motions as in Fig. 8. The position of alpha subunit L7-8 (shown in yellow) and the position of β subunit transmembrane span (shown in cyan) for β1β1, and the predicted positions of L7-8 (shown in yellow) and the transmembrane span for β2β2 (shown in cyan) were structurally aligned from the crystal structures used for the modeling (3WGU and 5YLU, respectively). The groove that would accommodate L7-8 is preserved in all cases.

(TIF)

pone.0321064.s009.tif (823.2KB, tif)
S8 Fig. Analysis of the movement contributions per dihedral angle.

Vertical numbers indicate interface residues while horizontal numbers indicate glycosylated asparagines. For ATP1B1, Chain A, the highest peaks are in 5 Φ angles (Asn193, Asp222, Tyr254, Asp269, Arg290) and 9 Ψ angles (Val72, Glu135, Arg136, Asp138, Phe139, Asn193, Lys253, Asp289, Arg290), while for Chain B the highest values are found in 10 Φ angles (Tyr68, Arg143, Gly144, Glu145, Ser160, Ser195, Lys216, Arg217, Asp222, Tyr254) and 15 Ψ angles (Tyr68, Asp70, Arg71, Gln84, Asn93, Arg143, Glu145, Gly161, Gly172, Asn193, Lys221, Lys253, Lys288, Phe291, Gly293). The distribution of peaks for ATP1B2 is somewhat different, as for Chain A the highest peaks are in 8 Φ angles (Asn90, Leu91, Cys129, Arg133, Gln137, Asn193, Ala266, Asn267) and 17 Ψ angles (Glu89, Asn90, Val128, Gly132, Glu136, Ala192, Met196, Asp205, Glu206, Tyr231, Asn264-Thr270) while for Chain B the highest values are in 3 Φ angles (Leu143, Phe188,Asp272) and 5 Ψ angles (Gln74, Gly141, Leu143, Asn187, Tyr189).

(TIF)

pone.0321064.s010.tif (319.5KB, tif)
S1 Video. Motion associated with ATP1B1 dimer, PC1.

(MP4)

Download video file (577KB, mp4)
S2 Video. Motion associated with ATP1B1 dimer, PC2.

(MP4)

Download video file (640.1KB, mp4)
S3 Video. Motion associated with ATP1B2 dimer, PC1.

(MP4)

Download video file (492.3KB, mp4)
S4 Video. Motion associated with ATP1B2 dimer, PC2.

(MP4)

Download video file (468.3KB, mp4)

Acknowledgments

The authors would like to thank the staff of the Computing Cluster Xiuhcoatl-Cinvestav (granted by LANCAD) and Hector Manuel Oliver Hernandez.

Data Availability

All relevant data are within the manuscript and its Supporting information files.

Funding Statement

CONAHCYT (Proyecto Ciencia Frontera CF-2023-G-1454). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Erecińska M, Silver IA. Ions and energy in mammalian brain. Prog Neurobiol 1994;43(1):37–71. doi: 10.1016/0301-0082(94)90015-9 [DOI] [PubMed] [Google Scholar]
  • 2.Craig WS, Kyte J. Stoichiometry and molecular weight of the minimum asymmetric unit of canine renal sodium and potassium ion-activated adenosine triphosphatase. J Biol Chem 1980;255(13):6262–9. doi: 10.1016/s0021-9258(18)43732-5 [DOI] [PubMed] [Google Scholar]
  • 3.Suhail M. Na, K-ATPase: ubiquitous multifunctional transmembrane protein and its relevance to various pathophysiological conditions. J Clin Med Res 2010;2(1):1–17. doi: 10.4021/jocmr2010.02.263w [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Clausen M, Hilbers F, Poulsen H. The structure and function of the Na,K-ATPase isoforms in health and disease. Front Physiol. 2017;8(371):1–16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Geering K. The functional role of beta subunits in oligomeric P-type ATPases. J Bioenerg Biomembr 2001;33(5):425–38. doi: 10.1023/a:1010623724749 [DOI] [PubMed] [Google Scholar]
  • 6.Blanco G. Na,K-ATPase subunit heterogeneity as a mechanism for tissue-specific ion regulation. Semin Nephrol 2005;25(5):292–303. doi: 10.1016/j.semnephrol.2005.03.004 [DOI] [PubMed] [Google Scholar]
  • 7.Jiao S, Johnson K, Moreno C, Yano S, Holmgren M. Comparative description of the mRNA expression profile of Na+/K+-ATPase isoforms in adult mouse nervous system. J Comp Neurol. 2022;530(3):627–47. doi: 10.1002/cne.25234 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Noguchi S, Mutoh Y, Kawamura M. The functional roles of disulfide bonds in the beta-subunit of (Na,K)ATPase as studied by site-directed mutagenesis. FEBS Lett. 1994;341(2–3):233–8. doi: 10.1016/0014-5793(94)80463-x [DOI] [PubMed]
  • 9.Tokhtaeva E, Munson K, Sachs G, Vagin O. N-glycan-dependent quality control of the Na,K-ATPase beta(2) subunit. Biochemistry 2010;49(14):3116–28. doi: 10.1021/bi100115a [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Kirley TL. Determination of three disulfide bonds and one free sulfhydryl in the beta subunit of (Na,K)-ATPase. J Biol Chem 1989;264(13):7185–92. doi: 10.1016/s0021-9258(18)83219-7 [DOI] [PubMed] [Google Scholar]
  • 11.Larsen BR, Assentoft M, Cotrina ML, Hua SZ, Nedergaard M, Kaila K, et al. Contributions of the Na+/K+-ATPase, NKCC1, and Kir4.1 to hippocampal K+ clearance and volume responses. Glia. 2014;62(4):608–22. doi: 10.1002/glia.22629 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Ackermann U, Geering K. Mutual dependence of Na,K-ATPase alpha- and beta-subunits for correct posttranslational processing and intracellular transport. FEBS Lett 1990;269(1):105–8. doi: 10.1016/0014-5793(90)81130-g [DOI] [PubMed] [Google Scholar]
  • 13.Shoshani L, Contreras RG, Roldan ML, Moreno J, Lazaro A, Balda MS, et al. The polarized expression of Na+, K+-ATPase in epithelia depends on the association between beta-subunits located in neighboring cells. Molecul Biol Cell. 2005;16(3):1013–1568. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Padilla-Benavides T, Roldán ML, Larre I, Flores-Benitez D, Villegas-Sepúlveda N, Contreras RG, et al. The polarized distribution of Na+, K+-ATPase: role of the interaction between beta subunits. Mol Biol Cell. 2010;21(13):2217–25. doi: 10.1091/mbc.e10-01-0081 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Tokhtaeva E, Sachs G, Sun H, Dada LA, Sznajder JI, Vagin O. Identification of the amino acid region involved in the intercellular interaction between the β1 subunits of Na+/K+-ATPase. J Cell Sci. 2012;125(Pt 6):1605–16. doi: 10.1242/jcs.100149 [DOI] [PMC free article] [PubMed]
  • 16.Páez O, Martínez-Archundia M, Villegas-Sepúlveda N, Roldan ML, Correa-Basurto J, Shoshani L. A Model for the homotypic interaction between Na+, K+-ATPase β1 subunits reveals the role of extracellular residues 221-229 in its Ig-like domain. Int J Mol Sci. 2019;20(18):4538. doi: 10.3390/ijms20184538 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Antonicek H, Persohn E, Schachner M. Biochemical and functional characterization of a novel neuron-glia adhesion molecule that is involved in neuronal migration. J Cell Biol 1987;104(6):1587–95. doi: 10.1083/jcb.104.6.1587 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Antonicek H, Schachner M. The adhesion molecule on glia (AMOG) incorporated into lipid vesicles binds to subpopulations of neurons. J Neurosci 1988;8(8):2961–6. doi: 10.1523/JNEUROSCI.08-08-02961.1988 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Gloor S, Antonicek H, Sweadner KJ, Pagliusi S, Frank R, Moos M, et al. The adhesion molecule on glia (AMOG) is a homologue of the beta subunit of the Na,K-ATPase. J Cell Biol 1990;110(1):165–74. doi: 10.1083/jcb.110.1.165 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Müller-Husmann G, Gloor S, Schachner M. Functional characterization of beta isoforms of murine Na,K-ATPase. The adhesion molecule on glia (AMOG/beta 2), but not beta 1, promotes neurite outgrowth. J Biol Chem 1993;268(35):26260–7. doi: 10.1016/s0021-9258(19)74309-9 [DOI] [PubMed] [Google Scholar]
  • 21.Shinoda T, Ogawa H, Cornelius F, Toyoshima C. Crystal structure of the sodium-potassium pump at 2.4 A resolution. Nature. 2009;459(7245):446–50. doi: 10.1038/nature07939 [DOI] [PubMed]
  • 22.Bab-Dinitz E, Albeck S, Peleg Y, Brumfeld V, Gottschalk KE, Karlish SJD. A C-terminal lobe of the beta subunit of Na,K-ATPase and H,K-ATPase resembles cell adhesion molecules. Biochemistry 2009;48(36):8684–91. doi: 10.1021/bi900868e [DOI] [PubMed] [Google Scholar]
  • 23.Lobato Alvarez JA, del Carmen Lopez Murillo T, Vilchis Nestor CA, Roldan Gutierrez ML, Paez O. Epithelial Na+, K+-ATPase — a sticky pump. In: Najman S, editor. Cell biology. Rijeka: IntechOpen; 2016. [Google Scholar]
  • 24.Roldán ML, Ramírez-Salinas GL, Martinez-Archundia M, Cuellar-Perez F, Vilchis-Nestor CA, Cancino-Diaz JC, et al. The β2-Subunit (AMOG) of Human Na+, K+-ATPase is a homophilic adhesion molecule. Int J Mol Sci. 2022;23(14):7753. doi: 10.3390/ijms23147753 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Waterhouse A, Bertoni M, Bienert S, Studer G, Tauriello G, Gumienny R, et al. SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Res. 2018;46(W1):W296–303. doi: 10.1093/nar/gky427 [DOI] [PMC free article] [PubMed]
  • 26.UniProt Consortium. UniProt: the universal protein knowledgebase in 2021. Nucleic Acids Res. 2021;49(D1):D480–9. doi: 10.1093/nar/gkaa1100 [DOI] [PMC free article] [PubMed]
  • 27.Jo S, Kim T, Iyer VG, Im W. CHARMM-GUI: a web-based graphical user interface for CHARMM. J Comput Chem 2008;29(11):1859–65. doi: 10.1002/jcc.20945 [DOI] [PubMed] [Google Scholar]
  • 28.Yan Y, Tao H, He J, Huang S-Y. The HDOCK server for integrated protein-protein docking. Nat Protoc 2020;15(5):1829–52. doi: 10.1038/s41596-020-0312-x [DOI] [PubMed] [Google Scholar]
  • 29.Jo S, Cheng X, Lee J, Kim S, Park S-J, Patel DS, et al. CHARMM-GUI 10 years for biomolecular modeling and simulation. J Comput Chem 2017;38(15):1114–24. doi: 10.1002/jcc.24660 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Sukhwal A, Sowdhamini R. Oligomerisation status and evolutionary conservation of interfaces of protein structural domain superfamilies. Mol Biosyst 2013;9(7):1652–61. doi: 10.1039/c3mb25484d [DOI] [PubMed] [Google Scholar]
  • 31.Krissinel E, Henrick K. Inference of macromolecular assemblies from crystalline state. J Mol Biol 2007;372(3):774–97. doi: 10.1016/j.jmb.2007.05.022 [DOI] [PubMed] [Google Scholar]
  • 32.Liu H, Hou T. CaFE: a tool for binding affinity prediction using end-point free energy methods. Bioinformatics 2016;32(14):2216–8. doi: 10.1093/bioinformatics/btw215 [DOI] [PubMed] [Google Scholar]
  • 33.Wang C, Greene D, Xiao L, Qi R, Luo R. Recent developments and applications of the MMPBSA method. Front Mol Biosci. 2018;4:87. doi: 10.3389/fmolb.2017.00087 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Martínez-Archundia M, Correa-Basurto J, Montaño S, Rosas-Trigueros JL. Studying the collective motions of the adenosine A2A receptor as a result of ligand binding using principal component analysis. J Biomol Struct Dyn 2019;37(18):4685–700. doi: 10.1080/07391102.2018.1564700 [DOI] [PubMed] [Google Scholar]
  • 35.Altis A, Nguyen P, Hegger R, Stock G. Dihedral angle principal component analysis of molecular dynamics simulations. J Chem Phys. 2007:126(24);244111. [DOI] [PubMed] [Google Scholar]
  • 36.Koukos PI, Glykos NM. Grcarma: A fully automated task-oriented interface for the analysis of molecular dynamics trajectories. J Comput Chem 2013;34(26):2310–2. doi: 10.1002/jcc.23381 [DOI] [PubMed] [Google Scholar]
  • 37.Tokhtaeva E, Sun H, Deiss-Yehiely N, Wen Y, Soni PN, Gabrielli NM, et al. The O-glycosylated ectodomain of FXYD5 impairs adhesion by disrupting cell-cell trans-dimerization of Na,K-ATPase β1 subunits. J Cell Sci. 2016;129(12):2394–406. doi: 10.1242/jcs.186148 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Vilchis-Nestor C, Roldán M, Leonardi A, Navea J, Padilla-Benavides T, Shoshani L. Ouabain enhances cell-cell adhesion mediated by β1 subunits of the Na+, K+-ATPase in CHO fibroblasts. Int J Molecul Sci. 2019;20(09):2111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Roa-Velázquez D, Xoconostle-Cázares B, Benítez-Cardoza CG, Ortega-López J, Shoshani L, Morales-Ríos E, et al. Expression, purification, and refolding of the recombinant extracellular domain β1-subunit of the dog Na+/K+-ATPase of the epithelial cells. Protein Expr Purif. 2022;200:106167. doi: 10.1016/j.pep.2022.106167 [DOI] [PubMed]
  • 40.Jayashree S, Murugavel P, Sowdhamini R, Srinivasan N. Interface residues of transient protein-protein complexes have extensive intra-protein interactions apart from inter-protein interactions. Biol Direct 2019;14(1):1. doi: 10.1186/s13062-019-0232-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Yan C, Wu F, Jernigan RL, Dobbs D, Honavar V. Characterization of protein-protein interfaces. Protein J 2008;27(1):59–70. doi: 10.1007/s10930-007-9108-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Fersht AR, Shi JP, Knill-Jones J, Lowe DM, Wilkinson AJ, Blow DM, et al. Hydrogen bonding and biological specificity analysed by protein engineering. Nature 1985;314(6008):235–8. doi: 10.1038/314235a0 [DOI] [PubMed] [Google Scholar]
  • 43.Mendoza JA, Jarstfer MB, Goldenberg DP. Effects of amino acid replacements on the reductive unfolding kinetics of pancreatic trypsin inhibitor. Biochemistry 1994;33(5):1143–8. doi: 10.1021/bi00171a013 [DOI] [PubMed] [Google Scholar]
  • 44.Pace CN, Horn G, Hebert EJ, Bechert J, Shaw K, Urbanikova L, et al. Tyrosine hydrogen bonds make a large contribution to protein stability. J Mol Biol 2001;312(2):393–404. doi: 10.1006/jmbi.2001.4956 [DOI] [PubMed] [Google Scholar]
  • 45.Green SM, Meeker AK, Shortle D. Contributions of the polar, uncharged amino acids to the stability of staphylococcal nuclease: evidence for mutational effects on the free energy of the denatured state. Biochemistry 1992;31(25):5717–28. doi: 10.1021/bi00140a005 [DOI] [PubMed] [Google Scholar]
  • 46.Yamagata Y, Kubota M, Sumikawa Y, Funahashi J, Takano K, Fujii S, et al. Contribution of hydrogen bonds to the conformational stability of human lysozyme: calorimetry and X-ray analysis of six tyrosine –> phenylalanine mutants. Biochemistry 1998;37(26):9355–62. doi: 10.1021/bi980431i [DOI] [PubMed] [Google Scholar]
  • 47.Shental-Bechor D, Levy Y. Effect of glycosylation on protein folding: a close look at thermodynamic stabilization. Proc Natl Acad Sci U S A 2008;105(24):8256–61. doi: 10.1073/pnas.0801340105 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Vagin O, Tokhtaeva E, Sachs G. The role of the beta1 subunit of the Na,K-ATPase and its glycosylation in cell-cell adhesion. J Biol Chem 2006;281(51):39573–87. doi: 10.1074/jbc.M606507200 [DOI] [PubMed] [Google Scholar]
  • 49.Vagin O, Sachs G, Tokhtaeva E. The roles of the Na,K-ATPase beta 1 subunit in pump sorting and epithelial integrity. J Bioenerg Biomembr. 2007;39(5–6):367–72. doi: 10.1007/s10863-007-9103-0 [DOI] [PubMed]
  • 50.He M, Zhou X, Wang X. Glycosylation: mechanisms, biological functions and clinical implications. Signal Transduct Target Ther 2024;9(1):194. doi: 10.1038/s41392-024-01886-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Tokhtaeva E, Sachs G, Souda P, Bassilian S, Whitelegge JP, Shoshani L, et al. Epithelial junctions depend on intercellular trans-interactions between the Na,K-ATPase β1 subunits. J Biol Chem. 2011;286(29):25801–12. doi: 10.1074/jbc.M111.252247 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Genheden S, Ryde U. The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities. Expert Opin Drug Discov 2015;10(5):449–61. doi: 10.1517/17460441.2015.1032936 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Maisuradze GG, Liwo A, Scheraga HA. Principal component analysis for protein folding dynamics. J Mol Biol 2009;385(1):312–29. doi: 10.1016/j.jmb.2008.10.018 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Lee HS, Qi Y, Im W. Effects of N-glycosylation on protein conformation and dynamics: Protein Data Bank analysis and molecular dynamics simulation study. Sci Rep. 2015;5:8926. doi: 10.1038/srep08926 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Scheidenhelm DK, Cresswell J, Haipek CA, Fleming TP, Mercer RW, Gutmann DH. Akt-dependent cell size regulation by the adhesion molecule on glia occurs independently of phosphatidylinositol 3-kinase and Rheb signaling. Mol Cell Biol 2005;25(8):3151–62. doi: 10.1128/MCB.25.8.3151-3162.2005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Kleene R, Loers G, Langer J, Frobert Y, Buck F, Schachner M. Prion protein regulates glutamate-dependent lactate transport of astrocytes. J Neurosci 2007;27(45):12331–40. doi: 10.1523/JNEUROSCI.1358-07.2007 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Heller M, von der Ohe M, Kleene R, Mohajeri MH, Schachner M. The immunoglobulin-superfamily molecule basigin is a binding protein for oligomannosidic carbohydrates: an anti-idiotypic approach. J Neurochem 2003;84(3):557–65. doi: 10.1046/j.1471-4159.2003.01537.x [DOI] [PubMed] [Google Scholar]
  • 58.Mishra NK, Habeck M, Kirchner C, Haviv H, Peleg Y, Eisenstein M, et al. Molecular mechanisms and kinetic effects of FXYD1 and phosphomimetic mutants on purified human Na,K-ATPase. J Biol Chem 2015;290(48):28746–59. doi: 10.1074/jbc.M115.687913 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Arystarkhova E, Ozelius LJ, Brashear A, Sweadner KJ. Misfolding, altered membrane distributions, and the unfolded protein response contribute to pathogenicity differences in Na,K-ATPase ATP1A3 mutations. J Biol Chem. 2021;296:100019. doi: 10.1074/jbc.RA120.015271 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Lee SJ, Litan A, Li Z, Graves B, Lindsey S, Barwe SP, et al. Na, K-ATPase β1-subunit is a target of sonic hedgehog signaling and enhances medulloblastoma tumorigenicity. Mol Cancer. 2015;14:159. doi: 10.1186/s12943-015-0430-1 [DOI] [PMC free article] [PubMed]
  • 61.Sun MZ, Kim JM, Oh MC, Safaee M, Kaur G, Clark AJ, et al. Na+/K+-ATPase β2-subunit (AMOG) expression abrogates invasion of glioblastoma-derived brain tumor-initiating cells. Neuro Oncol. 2013;15(11):1518–31. doi: 10.1093/neuonc/not099 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Barreto N, Caballero M, Bonfanti AP, de Mato FCP, Munhoz J, da Rocha-E-Silva TAA, et al. Spider venom components decrease glioblastoma cell migration and invasion through RhoA-ROCK and Na+/K+-ATPase β2: potential molecular entities to treat invasive brain cancer. Cancer Cell Int. 2020;20(1):576. doi: 10.1186/s12935-020-01643-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Litan A, Li Z, Tokhtaeva E, Kelly P, Vagin O, Langhans SA. A Functional Interaction Between Na,K-ATPase β2-Subunit/AMOG and NF2/Merlin Regulates Growth Factor Signaling in Cerebellar Granule Cells. Molecular Neurobiology. 2019;56(11):7557–7571 [DOI] [PMC free article] [PubMed] [Google Scholar]
PLoS One. 2025 Apr 29;20(4):e0321064. doi: 10.1371/journal.pone.0321064.r001

Author response to Decision Letter 0


Transfer Alert

This paper was transferred from another journal. As a result, its full editorial history (including decision letters, peer reviews and author responses) may not be present.

10 Sep 2024

Decision Letter 0

Colin Johnson

24 Oct 2024

PONE-D-24-40078In silico studies provide new structural insights into trans-dimerization of β1 and β2 subunits of the Na+,K+-ATPasePLOS ONE

Dear Dr. Shoshani,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Specifically, both reviewers commented that the manuscript contains a few grammar errors that should be addressed. Concern over the lack of description of the cluster analysis used in the study as well as what glycan residues are included. Please adderess the points raised by both reviewers in a revised manuscript.

Please submit your revised manuscript by Dec 08 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Colin Johnson, Ph.D.

Academic Editor

PLOS ONE

Journal requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please note that PLOS ONE has specific guidelines on code sharing for submissions in which author-generated code underpins the findings in the manuscript. In these cases, we expect all author-generated code to be made available without restrictions upon publication of the work. Please review our guidelines at https://journals.plos.org/plosone/s/materials-and-software-sharing#loc-sharing-code and ensure that your code is shared in a way that follows best practice and facilitates reproducibility and reuse.

3. Thank you for stating the following financial disclosure:

“CONAHCYT (Proyecto Ciencia Frontera CF-2023-G-1454).”

Please state what role the funders took in the study.  If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."

If this statement is not correct you must amend it as needed.

Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf.

4. Thank you for stating the following in the Acknowledgments Section of your manuscript:

“MMA thanks CONAHCYT for the Ciencia Frontera Project

CF-2023-G-1454.

MMA and GRS thank Computing Cluster Xiuhcoatl-Cinvestav (granted by

LANCAD) and Hector Manuel Oliver Hernandez.

JLRT thanks SIP-IPN 20240801, SIBE-IPN and EDI-IPN.”

We note that you have provided funding information that is currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form.

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows:

“CONAHCYT (Proyecto Ciencia Frontera CF-2023-G-1454).”

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

5. Please provide a complete Data Availability Statement in the submission form, ensuring you include all necessary access information or a reason for why you are unable to make your data freely accessible. If your research concerns only data provided within your submission, please write "All data are in the manuscript and/or supporting information files" as your Data Availability Statement.

6. We notice that your supplementary figures and tables are included in the manuscript file. Please remove them and upload them with the file type 'Supporting Information'. Please ensure that each Supporting Information file has a legend listed in the manuscript after the references list.

7. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: I Don't Know

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: No

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: This is an interesting paper using computational protein structure analyses to explore the differences in intercellular interactions of two homologs of Na,K-ATPase beta subunit. The authors are clear in their assumptions and in the use of a number of modeling methods to predict the extent and stability of the different homotypic protein-protein interactions. The conclusions are compared to what is known about the ability of the proteins to anchor cells into clusters.

There are minor questions to be answered.

1. Fig. 1 What is the orientation relative to alpha subunit. I.e. are we looking at it from the side or the top?

2. Which exact amino acid residues are included in the models?

3. Fig. 1, 2, and 8. It would be welcome to have stereo images in a supplement.

4. Please make it clear what glycan residues are included in the model. It seems to be only GlcNAc on the asparagines; is this right? Can you present an estimate of the minimum volume occupied by the actual complex glycan present in vivo, and whether the volume is enough to block interaction. Reference 45 from Schachner implicates oligomannosidic groups.

5. I could not understand Fig. 8 because the two models have different relative tilts. Can you add a duplicate of the figure with the position of alpha subunit L7-8 and position of beta transmembrane span for b1-b1, and the predicted positions of L7-8 and the transmembrane span for b2-b2? I think that L7-8 ought to dock into each model. If not, that should be stated, and I think that the model could be rebuilt including L7-8. Isn’t the interaction with alpha a constraint on the beta head models?

6. P. 31. What was achieved by producing a model of b1 with the Swiss Model program? How did it differ from 3WGU?

English:

eventhoh should be even though, and remove the comma

This should be one sentence with a comma: “The normalized energy per residue is around -2 kJ/mol in various conformers of β1-β1. While in β2-β2 none of the conformers reached that value.”

Molecular dynamics simulations along mathematical applications are... Along with?

Reviewer #2: The paper presents a well-executed study using MD simulations to investigate the differences in stability between the β1 and β2 subunits of the Na+,K+-ATPase in the context of their potential to form trans-dimers. The focus is on analyzing the structural stability in trans-dimerization of these subunits, with additional discussion on the role of glycosylation. However, it is important to note that no comparison is made with 3D structures lacking glycosylation, which limits the depth of the glycosylation analysis.

The manuscript would benefit from a language revision, as several sections contain unclear sentences. The use of references could be improved. In some sections, reference numbers are used instead of author names in the middle of a sentence, which disrupts the flow of the text.

Due to the lack of an available crystal structure for ATP1B2 the homologous pig gastric H,K-ATPase was used to build the model for the β2 subunit. For the analysis of the 3D models there is a discrepancy in the reporting of Ramachandran plots. For β1, the text mentions that 99% of residues are in allowed regions, while β2 is reported as 100%. However, the legend for Figure 1 claims none of the residues are in disallowed regions, yet the plot indicates that some residues are indeed in disallowed zones. This needs to be clarified.

In Table 2, the title incorrectly refers to the β1 dimer, while the content clearly discusses the β2 dimer. This should be corrected.

One important point that needs to be addressed is the lack of description of the cluster analysis which is used to draw conclusions about the stability of β1 and β2 dimers. The cluster analysis is central to the paper’s conclusions, yet there is insufficient explanation of the methods and presentation of the results. Supplementary Figure S2 suggests potential alternative interpretations, which should be discussed more thoroughly. Figure S2 should be combined with figure 7 for this discussion.

Finally, the concluding remark speculating on β2's interaction with a neural receptor to gain stability in trans-dimers may be somewhat premature. While the idea is intriguing, it may be more productive to explore potential interactions between β2 and other components of the Na+,K+-ATPase complex, e.g. the γ/FXYD subunits.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: Hjalmar Brismar

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2025 Apr 29;20(4):e0321064. doi: 10.1371/journal.pone.0321064.r003

Author response to Decision Letter 1


22 Dec 2024

Reviewer #1: This is an interesting paper using computational protein structure analyses to explore the differences in intercellular interactions of two homologs of Na,K-ATPase beta subunit. The authors are clear in their assumptions and in the use of a number of modeling methods to predict the extent and stability of the different homotypic protein-protein interactions. The conclusions are compared to what is known about the ability of the proteins to anchor cells into clusters.

There are minor questions to be answered.

1. Fig. 1 What is the orientation relative to alpha subunit. I.e. are we looking at it from the side or the top?

Thanks. We modified the orientation of the two models in Fig 1. Now We added this information to the figure legend.

“The extracellular domain of the β1 and β2 subunits depicted in A and C is with the N-terminal (residues 63 and 70) colored in yellow and the C-terminal (residues 303 and 289) in green. The distinctive alpha-helix of the β-subunits is localized in the bottom. For relative orientation to the alpha subunit, see S7 Figure.”

2. Which exact amino acid residues are included in the models?

ATP1B1 model shows the following range of residues: 63 to 303 for both of the chains.

ATP1B2 model shows the following range of residues: 70 to 289 for both of the chains.

This information was added to the text. Thanks.

3. Fig. 1, 2, and 8. It would be welcome to have stereo images in a supplement.

The suggested stereo images are now added as S3-S6 figures .

4. Please make it clear what glycan residues are included in the model. It seems to be only GlcNAc on the asparagines; is this right?

Thanks for the observation. As stated in “Participation of N-glycosylated residues in the dimeric interface” section; the type of glycosylations that were considered for the proteic models was N-acetylglucosamine (GlcNAc) to the nitrogen atom of an asparagine (N) side chain. We were also interested in including more sugars and evaluated the possibility to glycosylate in silico the beta-subunits of our interest. CHARMM-GUI has implemented Glycan Reader which permits the simulation of glycans and glycoconjugates. Glycan Reader not only detects most sugar types and chemical modifications in the PDB, but also allows users to edit the glycan sequences through addition/deletion/change of sugar types, chemical modifications, glycosidic linkages, and anomeric states. However, CHARMM-GUI Glycan Reader does not support in silico glycosylation and addition of a sugar at the reducing end of an existing glycan chain. (https://academic.oup.com/glycob/article/29/4/320/5301306). Therefore, we had to leave it as it is, with the GlcNAc molecule only.

Can you present an estimate of the minimum volume occupied by the actual complex glycan present in vivo, and whether the volume is enough to block interaction. Reference 45 from Schachner implicates oligomannosidic groups.

About ref. 45 (first version) this work was realized with mouse brain membranes. We can not be certain that human b2 has the same composition.

Anyway, this is indeed an interesting point for discussion. Unfortunately, we could not find any computational tool for calculating the sugar volume. Nevertheless, the steric effect of the sugars on the protein surface was considered in different studies and in fact, there are studies showing that it is relevant for both stabilizing the protein structure and for de-stabilizing it. Nevertheless, the N-glycosylation effect on protein-protein interactions is much more complex than simply analyzing its steric impediments. Different studies with a biophysical approach, analyzed the role of the N-linked sugar on protein folding and protein aggregation. Thus, Gavrilov et al. (2015; DOI: 10.1021/acs.jpclett.5b01588) showed that although natural glycosylation results in protein stabilization; in vitro and in silico studies show that sometimes glycosylation results in thermodynamic destabilization. Though glycosylation creates new short-range glycan–protein interactions that stabilize the conjugated protein, it breaks long-range protein–protein interactions. The destabilization originates not from simple loss of interactions but due to a trade-off between the short- and long-range interactions. Another interesting work published recently (Doran-Romana et al. 2024; DOI: 10.1126/sciadv.adk8173) shows the role of N-glycosylation as a protective mechanism against protein aggregation in eukaryotic cells. Nevertheless, as the focus of our study is on protein-protein interaction, we looked for studies that analyze this aspect. Qasba (2000) reviewed studies about the involvement of sugars in protein–protein interactions. This review emphasizes the complexity of that issue. “The oligosaccharide moiety in the carbohydrate-dependent recognition process orients the molecules in a way that brings about specific protein–protein or protein–carbohydrate interactions. As these interactions occur with a unique conformer of the oligosaccharide, the knowledge of the conformation of carbohydrates is important. A given oligosaccharide can exist in several conformations (Rao, Qasba, Balaji & Chandrasekaran, 1998), and it is the interaction between a unique conformer and a macromolecule that is required to initiate a biological response. Hence, it is essential to have detailed information about all the conformers that are accessible to an oligosaccharide.”

In the case of β2/AMOG, it is assumed to participate in both protein-protein (Roldan et al. 2022) and protein carbohydrate interactions (Heller et al. 2003). This makes it even more complicated. We do not know the carbohydrate structure nor its conformers, as the N-linked oligosaccharides of the human β2/AMOG were not studied or reported, at least we did not find that information. There is no crystal for β2/AMOG of any species and if it was, probably it would not have information about the linked sugars, as they would interfere with the crystallization of the protein.

All that discussion is out of the main scope of our work and requires much more studies therefore we do not include all of it in the manuscript but do make some clarifications along the manuscript that are highlighted in there.

5. I could not understand Fig. 8 because the two models have different relative tilts. Can you add a duplicate of the figure with the position of alpha subunit L7-8 and position of beta transmembrane span for b1-b1, and the predicted positions of L7-8 and the transmembrane span for b2-b2? I think that L7-8 ought to dock into each model. If not, that should be stated, and I think that the model could be rebuilt including L7-8.

The requested figure has been added as Fig. S7. The addition of elements into the system would of course modify the dynamics of the dimers, but we believe our results highlight a dramatic contrast in the tendencies of these dimers.

Isn’t the interaction with alpha a constraint on the beta head models?

Yes, of Course, and therefore, one of the criteria for selecting the most probable dimer (for b1-b1 and b2-b2) out of the docking results, is the orientation of the beta ectodomain. Selecting those that represent a trans orientation on membranes of two neighboring cells as mentioned in the manuscript. On the other hand, the domain that interacts with L7-8 of the alpha subunit is not involved in beta-beta interface. The adhesive interface is in the c-terminal (Ig-like) domain of the beta-subunit. At least for the beta1 subunit we have shown that the soluble extracellular domain (secreted from transfected CHO cells) is adhesive and mutations in hot spot residues of the proposed interface decreases cell-cell and protein-protein adhesion (Paez et al. 2019).

6. P. 31. What was achieved by producing a model of b1 with the Swiss Model program? How did it differ from 3WGU?

The identity between Human b1 subunit (P05026) and wild boar b1 subunit (3WGU) is 92.41%. As we were interested in studying the intermolecular interactions, we had to consider that the 7.6% difference in sequence could result in a different behaviour of protein-protein interactions. Therefore it was important to work with a structural model. When we compare the 3D structure of those two proteins, we find a homology of 95.5%.

Thanks, we have made this correction.

This should be one sentence with a comma: “The normalized energy per residue is around -2 kJ/mol in various conformers of β1-β1. While in β2-β2 none of the conformers reached that value.”

Ok, this paragraph has been corrected.

Molecular dynamics simulations along mathematical applications are... Along with?

Ok, this paragraph has been corrected.

Here is our reply (in blue) to Reviewer #2.

Reviewer #2: The paper presents a well-executed study using MD simulations to investigate the differences in stability between the β1 and β2 subunits of the Na+,K+-ATPase in the context of their potential to form trans-dimers. The focus is on analyzing the structural stability in trans-dimerization of these subunits, with additional discussion on the role of glycosylation. However, it is important to note that no comparison is made with 3D structures lacking glycosylation, which limits the depth of the glycosylation analysis.

1) The manuscript would benefit from a language revision, as several sections contain unclear sentences.

The use of references could be improved. In some sections, reference numbers are used instead of author names in the middle of a sentence, which disrupts the flow of the text.

Thanks for the observation. New references were added:

We found one case for the number instead of the author name and corrected it.

2) Due to the lack of an available crystal structure for ATP1B2 the homologous pig gastric H,K-ATPase was used to build the model for the β2 subunit. For the analysis of the 3D models there is a discrepancy in the reporting of Ramachandran plots. For β1, the text mentions that 99% of residues are in allowed regions, while β2 is reported as 100%. However, the legend for Figure 1 claims none of the residues are in disallowed regions, yet the plot indicates that some residues are indeed in disallowed zones. This needs to be clarified.

Thanks for the observation. We corrected it in the figure legend. It now says: “Ramachandran plot of the β1 subunit monomer where it can be seen that only 1% of the residues of the proteins are included in the disallowed regions”.

3) In Table 2, the title incorrectly refers to the β1 dimer, while the content clearly discusses the β2 dimer. This should be corrected.

Thanks. The title of Table 2 has been corrected.

4) One important point that needs to be addressed is the lack of description of the cluster analysis which is used to draw conclusions about the stability of β1 and β2 dimers. The cluster analysis is central to the paper’s conclusions, yet there is insufficient explanation of the methods and presentation of the results.

OK. We added an explanation in a separate section in “Methods” titled: PCA-based cluster analysis.

5) Supplementary Figure S2 suggests potential alternative interpretations, which should be discussed more thoroughly. Figure S2 should be combined with figure 7 for this discussion.

The discussion of the regions with the highest density has been rewritten. We hope it is clearer now.

6) Finally, the concluding remark speculating on β2's interaction with a neural receptor to gain stability in trans-dimers may be somewhat premature.

You are right. This idea at the concluding remark was misunderstood. We now comment on the heterophilic interaction of the b2-subunit in “Discussion” and hope it is now more coherent and not speculative.

While the idea is intriguing, it may be more productive to explore potential interactions between β2 and other components of the Na+,K+-ATPase complex, e.g. the γ/FXYD subunits.

It is indeed interesting and we added this possibility in the discussion. Nevertheless, our interest and focus is on the trans-interaction with another beta-subunit or another unknown protein on the neuron surface.

Attachment

Submitted filename: Response to Reviewers.docx

pone.0321064.s015.docx (294.7KB, docx)

Decision Letter 1

Colin Johnson

8 Jan 2025

PONE-D-24-40078R1In silico studies provide new structural insights into trans-dimerization of β1 and β2 subunits of the Na+,K+-ATPasePLOS ONE

Dear Dr. Shoshani,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Specifically the reviewers require the correction of technical errors in the manuscript including problems with the representation of symbols and greek letters in the document file. In addition it was also thought that enlargement of the stereo images in the supplemental figure would be helpful to the reader.

Please submit your revised manuscript by Feb 22 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Colin Johnson, Ph.D.

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: (No Response)

Reviewer #2: (No Response)

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: No

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Just a very minor request: for the stereo pictures in the supplement, they could be view at larger magnification if there was less white space between the images.

Reviewer #2: While the manuscript appears to be scientifically sound and likely acceptable for publication, the formatting issues in the submitted version are concerning. It reflects poorly on the submission process when such apparent errors are overlooked. Specifically, Greek letters are represented as empty boxes in the PDF, which makes it impossible to perform a thorough final review and provide a definitive recommendation in its current state.

Before resubmitting, I strongly urge the authors to double check that the manuscript is fully readable and that all formatting issues are resolved. See already on first page with several formatting errors.

Also correct Line 285: use the greek letter beta for the subunits as in other parts of the manuscript.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: Hjalmar Brismar

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2025 Apr 29;20(4):e0321064. doi: 10.1371/journal.pone.0321064.r005

Author response to Decision Letter 2


5 Feb 2025

Estimated reviewers

We appreciate the time and efforts that you have dedicated to read and revise our manuscript again.

Here is our reply (in blue) to Reviewer #1.

Reviewer #1: Just a very minor request: for the stereo pictures in the supplement, they could be view at larger magnification if there was less white space between the images.

The images (Fig S3-S6) were corrected and they are now larger. Thanks.

Here is our reply (in blue) to Reviewer #2.

1. While the manuscript appears to be scientifically sound and likely acceptable for publication, the formatting issues in the submitted version are concerning. It reflects poorly on the submission process when such apparent errors are overlooked. Specifically, Greek letters are represented as empty boxes in the PDF, which makes it impossible to perform a thorough final review and provide a definitive recommendation in its current state.

We are very sorry for that. As you could notice by downloading the Word Document itself, not the PDF, the symbols and Greek letters are OK. This problem was generated by the system, when converting all uploaded files to one PDF document.

The corresponding author revised the document before submitting it, actually the system does not permit to continue if the author does not open the file and revise it. For a strange reason, we did not notice this error and we apologize for it.

2. Before resubmitting, I strongly urge the authors to double check that the manuscript is fully readable and that all formatting issues are resolved. See already on first page with several formatting errors.

-It is double checked now and we hope you will get it as it is.

3. Also correct Line 285: use the Greek letter beta for the subunits as in other parts of the manuscript.

Thanks for your observation. It is now in Greek letter.

Attachment

Submitted filename: Response to Reviewers R2.docx

pone.0321064.s016.docx (17.8KB, docx)

Decision Letter 2

Colin Johnson

3 Mar 2025

In silico studies provide new structural insights into trans-dimerization of β1 and β2 subunits of the Na+,K+-ATPase

PONE-D-24-40078R2

Dear Dr. Shoshani,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Colin Johnson, Ph.D.

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: (No Response)

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: (No Response)

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: (No Response)

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: (No Response)

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: (No Response)

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: (No Response)

Reviewer #2: Thanks, all comments regarding formatting of greek letters have been fully adressed. I look forward to the published version of this interesting paper.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: Hjalmar Brismar

**********

Acceptance letter

Colin Johnson

PONE-D-24-40078R2

PLOS ONE

Dear Dr. Shoshani,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Colin Johnson

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Table. Interactions in the interface calculated in the different conformations of ATP1B1 and ATP1B2.

    (DOCX)

    pone.0321064.s001.docx (138.2KB, docx)
    S2 Table. Interactions in the interface calculated in the different conformations of ATP1B1 and ATP1B2 dimers.

    The interaction is expressed as pseudo energy, whose ranges have been standardized using known sets of protein-protein complexes.

    (DOCX)

    pone.0321064.s002.docx (139.6KB, docx)
    S1 Fig. Cumulative contribution of the principal components to the variance in the structural space.

    The first principal components for both dimers explain under 40% of the energy observed in the simulation. Reaching 80% requires over 100 principal components, which suggests the simulation time might have to be extended to allow fewer motions to dominate the dynamics. The projections of the trajectories onto PC1 and PC2 are very different, which was expected as the sequences show only partial similarity. Regarding the cluster analysis, some clusters of similar size to the main cluster are observed, which correlates with the poor dominance shown by the main principal components and hints at the possibility of a main energetic basin still waiting to be populated. The motions associated with the two main principal components for ATP1B1 show symmetric, rotatory behaviors that are expected in a stable dimer. In contrast, for ATP1B2, PC1 shows an asymmetric, longitudinal motion that seems to drive the monomers away from each other while PC2 seems to involve mostly inconsequential motions in the most mobile loops. This behavior can be related to Table I, where ATP1B2 shows unfavorable interactions for several of the conformations considered.

    (TIF)

    pone.0321064.s003.tif (240.2KB, tif)
    S2 Fig. dPCA Cluster analysis considering the first two principal components of β1β1 and β2β2 dimers.

    For ATP1B1 we have the main cluster around low values of PC1, whereas the main cluster for ATP1B2 is in a region with large values for both PC1 and PC2, and it also spans a larger region. These observations support the conclusion that ATP1B1 shows a stable interface and the lack thereof for ATP1B2.

    (TIF)

    pone.0321064.s004.tif (327KB, tif)
    S3 Fig. Motion associated with ATP1B1 dimer, PC1, stereo image.

    Chain A goes from red in the N-terminus to white in the C-terminus while chain B goes from white in the N-terminus to blue in the C-terminus. Green tubes show the motion associated with the principal components. The motion for PC1 is concerted, symmetric and rotatory, suggesting that a stable interface is reached in the simulation for this dimer.

    (TIF)

    pone.0321064.s005.tiff (633.9KB, tiff)
    S4 Fig. Motion associated with ATP1B1 dimer, PC2, stereo image.

    Chain A goes from red in the N-terminus to white in the C-terminus while chain B goes from white in the N-terminus to blue in the C-terminus. Green tubes show the motion associated with the principal components. The motion for PC2 shows less amplitude than the motion for PC1, but is also concerted, symmetric and rotatory, suggesting that a stable interface is reached in the simulation for this dimer.

    (TIF)

    pone.0321064.s006.tiff (591.3KB, tiff)
    S5 Fig. Motion associated with ATP1B2 dimer, PC1, stereo image.

    Chain A goes from red in the N-terminus to white in the C-terminus while chain B goes from white in the N-terminus to blue in the C-terminus. Green tubes show the motion associated with the principal components. The motion for PC1 is longitudinal instead of rotatory and shows a tendency to increase the distance between the monomers, which suggests that a stable dimer is not reached in the simulation.

    (TIF)

    pone.0321064.s007.tiff (1,002.9KB, tiff)
    S6 Fig. Motion associated with ATP1B2 dimer, PC2, stereo image.

    Chain A goes from red in the N-terminus to white in the C-terminus while chain B goes from white in the N-terminus to blue in the C-terminus. Green tubes show the motion associated with the principal components. The motion for PC2 does not involve significantly the interface residues, which is consistent with the lack of a stable interface for this dimer.

    (TIF)

    pone.0321064.s008.tiff (809.3KB, tiff)
    S7 Fig. Motion associated with PC1 and PC2 of β1 and β2 dimers, with structural references.

    Coloring of the dimers and the associated motions as in Fig. 8. The position of alpha subunit L7-8 (shown in yellow) and the position of β subunit transmembrane span (shown in cyan) for β1β1, and the predicted positions of L7-8 (shown in yellow) and the transmembrane span for β2β2 (shown in cyan) were structurally aligned from the crystal structures used for the modeling (3WGU and 5YLU, respectively). The groove that would accommodate L7-8 is preserved in all cases.

    (TIF)

    pone.0321064.s009.tif (823.2KB, tif)
    S8 Fig. Analysis of the movement contributions per dihedral angle.

    Vertical numbers indicate interface residues while horizontal numbers indicate glycosylated asparagines. For ATP1B1, Chain A, the highest peaks are in 5 Φ angles (Asn193, Asp222, Tyr254, Asp269, Arg290) and 9 Ψ angles (Val72, Glu135, Arg136, Asp138, Phe139, Asn193, Lys253, Asp289, Arg290), while for Chain B the highest values are found in 10 Φ angles (Tyr68, Arg143, Gly144, Glu145, Ser160, Ser195, Lys216, Arg217, Asp222, Tyr254) and 15 Ψ angles (Tyr68, Asp70, Arg71, Gln84, Asn93, Arg143, Glu145, Gly161, Gly172, Asn193, Lys221, Lys253, Lys288, Phe291, Gly293). The distribution of peaks for ATP1B2 is somewhat different, as for Chain A the highest peaks are in 8 Φ angles (Asn90, Leu91, Cys129, Arg133, Gln137, Asn193, Ala266, Asn267) and 17 Ψ angles (Glu89, Asn90, Val128, Gly132, Glu136, Ala192, Met196, Asp205, Glu206, Tyr231, Asn264-Thr270) while for Chain B the highest values are in 3 Φ angles (Leu143, Phe188,Asp272) and 5 Ψ angles (Gln74, Gly141, Leu143, Asn187, Tyr189).

    (TIF)

    pone.0321064.s010.tif (319.5KB, tif)
    S1 Video. Motion associated with ATP1B1 dimer, PC1.

    (MP4)

    Download video file (577KB, mp4)
    S2 Video. Motion associated with ATP1B1 dimer, PC2.

    (MP4)

    Download video file (640.1KB, mp4)
    S3 Video. Motion associated with ATP1B2 dimer, PC1.

    (MP4)

    Download video file (492.3KB, mp4)
    S4 Video. Motion associated with ATP1B2 dimer, PC2.

    (MP4)

    Download video file (468.3KB, mp4)
    Attachment

    Submitted filename: Response to Reviewers.docx

    pone.0321064.s015.docx (294.7KB, docx)
    Attachment

    Submitted filename: Response to Reviewers R2.docx

    pone.0321064.s016.docx (17.8KB, docx)

    Data Availability Statement

    All relevant data are within the manuscript and its Supporting information files.


    Articles from PLOS One are provided here courtesy of PLOS

    RESOURCES